Page 5,294«..1020..5,2935,2945,2955,296..5,3005,310..»

Stroke patients respond similarly to after-stroke care, despite age difference

Posted: Published on May 17th, 2013

Public release date: 17-May-2013 [ | E-mail | Share ] Contact: Neale Chumbler chumbler@uga.edu 706-369-5975 University of Georgia Athens, Ga. Age has little to do with how patients should be treated after suffering a stroke, according to new research from the University of Georgia. Historically, younger stroke victims receive different after-stroke intervention strategies than those over a certain age. However, Neale Chumbler, a UGA professor and head of the department of health policy and management in the College of Public Health, found patients responded equally to care efforts. Looking at 127 Veterans Affairs medical centers and a sample of 3,196 patients treated for ischemic strokes, or strokes caused by blood clots, Chumbler studied patient response to care quality as outpatients and if the response changed based on age. To determine risk, he looked at depression symptoms, responses to blood thinning medications and average blood pressure, blood sugar and cholesterol levels over a period of six months after patients were released from the hospital following a stroke. He found little difference in health quality across the patients regardless of age. The results of the study were published in the April issue of the Journal of Rehabilitation Research and Development. "Watching these … Continue reading →

Comments Off on Stroke patients respond similarly to after-stroke care, despite age difference

Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine

Posted: Published on May 17th, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (ACOR) today announced that the Companys Legal department has been selected by Corporate Counsel magazine as one of the four Best Legal Departments 2013. We are delighted by this honor, said Jane Wasman, Acordas President, International and General Counsel. As a department, we aim to creatively and effectively solve complex legal issues, and much of our success is attributable to strategically partnering with other departments across our organization to advance business objectives in a compliant manner. The growth of our company, and the extensive regulation of the pharmaceutical industry, continually creates new challenges for us to tackle, and we appreciate this recognition of our efforts. In selecting the Best Legal Departments 2013, Corporate Counsel evaluated a wide range of legal departments across the country and across all industries, including Fortune 500 companies, small start-ups, and not-for-profits. Ms. Wasman joined Acorda in 2004 as General Counsel. Her team is responsible for all of the Company's legal issues, including such critical areas such as FDA and SEC compliance, interactions with healthcare professionals and payers, intellectual property strategy and prosecution, product development and promotion, and contracts. The full article on the 2013 Best Legal Departments is available … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine

Kessler Foundation Names Dr. Ross Zafonte Recipient of Foundation's 3rd Annual DeLisa Award

Posted: Published on May 17th, 2013

WEST ORANGE, NJ--(Marketwired - May 17, 2013) - Ross Zafonte, D.O., is the 2013 recipient of Kessler Foundation's Joel A. DeLisa, MD Award for Excellence in Research and Education in the Field of Physical Medicine & Rehabilitation (PM&R). Dr. Zafonte will be honored at the Foundation's Board of Trustees Recognition Dinner in Cedar Grove on May 22. The award includes a $50,000 unrestricted grant for Dr. Zafonte's research activities. An expert on brain injury, Dr. Zafonte is the Harvard Medical School Earle P. and Ida S. Charlton Professor and Chair of Physical Medicine and Rehabilitation at Harvard Medical School and Vice President of Medical Affairs at Spaulding Rehabilitation Hospital. He also serves as Chief of Physical Medicine and Rehabilitation at Massachusetts General Hospital. His textbook, Brain Injury Medicine: Principles and Practice, is considered one of the standards in brain injury care. He is currently studying the impact of multiple concussions as well as innovative agents to enhance recovery after brain and spinal cord injury. He is also principal investigator (PI) on a study that evaluates the role of specific pharmacotherapy to treat long-term cognitive deficits after traumatic brain injury (TBI). "The Foundation is pleased to honor Dr. Zafonte, who is … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on Kessler Foundation Names Dr. Ross Zafonte Recipient of Foundation's 3rd Annual DeLisa Award

West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug

Posted: Published on May 17th, 2013

West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug By Dennis Romboy May 17th, 2013 @ 11:40am SALT LAKE CITY A West Jordan man charged with selling a Viagra-like drug as a natural supplement has pleaded guilty to charges in two separate federal indictments. Kelly Dean Harvey, 50, admitted to conspiring with two others to make and sell male sexual enhancement and erectile dysfunction products under false pretenses. The products were advertised online as "100 percent natural," but tests by the Food and Drug Administration found they contained a chemical imported from China similar to Viagra's active ingredient. Harvey didn't disclose that the products could be dangerous for people with heart conditions, according to the FDA, which issued several warnings to consumers. Harvey pleaded guilty Wednesday in federal court to conspiracy, wire fraud, mail fraud and concealment money laundering in connection with the case and agreed to forfeit $512,731. In the second case, Harvey pleaded guilty to one count of conspiracy to import and importation of ephedrine and one count of conspiracy to commit money laundering. He admitted that between August 2007 and April 2011 he conspired with two others to ship ephedrine from India to the United … Continue reading →

Posted in Male Sexual Dysfunction | Comments Off on West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug

InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

Posted: Published on May 17th, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company will be conducting a webcast of the Annual Shareholders Meeting scheduled for Thursday, May 23, 2013 at 10:00 a.m. Eastern Daylight Time at the offices of Greenberg Traurig, LLP at One International Place, Boston, MA 02110. The webcast can be accessed by interested shareholders and other parties at https://viavid.webcasts.com/starthere.jsp?ei=1017369. The meeting will also be accessible by telephone in listen-only mode. From the US, please dial 1-877-941-2068; from outside the US, please dial 1-480-629-9712. All participants should reference Conference ID 4620317. Slides from the meeting will be available to those viewing the webcast,and a replay of the webcast including presentation slides will also be available under the Investor Relations section of the InVivo Therapeutics website within 24 hours. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed from traumatic spinal cord injuries. The company was founded in 2005 based on proprietary technology co-invented by Robert S. Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

The Dangers Lurking in Male Sexual Supplements

Posted: Published on May 17th, 2013

Maciej Frolow / Getty Images Rock Hard and similar so-called natural supplements for men often contain potentially dangerous drugs some of which have never been tested on animals, let alone humans. In an editorial published in JAMA Internal Medicine, Pieter Cohen, assistant professor of medicine at Harvard Medical School and a colleague collected some of the lesser known facts about an industry that produces millions of pills and likely generates tens of millions, if not billions of dollars in profits but is almost entirely free of government oversight. Heres what they found: * A product sold as Rock Hard for Men in 2012 turned out to contain not only counterfeit Cialis (tadalafil) but also a diabetes drug that can be deadly if used incorrectly. A similar combination killed more than a dozen men in Asia in 2009. * One Utah company alone produced more than a million pharmaceutically-tainted pills monthly, earning $2 million between 2007 and 2010, according to an indictment issued in one of the few cases brought against such manufacturers. * More than three-quarters of male enhancement supplements tested in one study in Singapore contained pharmaceuticals that were not disclosed and half of them were present in higher … Continue reading →

Posted in Male Sexual Dysfunction | Comments Off on The Dangers Lurking in Male Sexual Supplements

Higher testosterone, vegans or carnivores – Video

Posted: Published on May 17th, 2013

Higher testosterone, vegans or carnivores http://nutritionfacts.org/ Dr Gregors site, look for him on YouTube, search for nutritionfacts.org Stronglifts.com - This site does have really great trainin... By: Justin Morgan … Continue reading →

Posted in Testosterone | Comments Off on Higher testosterone, vegans or carnivores – Video

Breakthrough in human cloning raises hopes for treatment of Parkinson's and heart disease

Posted: Published on May 17th, 2013

Scientists have finally made the long-awaited breakthrough in human cloning by turning skin cells into early-stage embryos that were then used to create specialised tissue cells for transplant operations, it has been revealed today. For the first time, researchers have unequivocally created human embryonic stem cells using the cloning technique that led to the birth of Dolly the sheep. However, unlike Dolly, the human embryos were destroyed when their stem cells were extracted. The scientific milestone, which comes 17 years after the birth of Dolly, represents a major turning point in human cloning research which could now lead to new tissue-transplant operations for a range of debilitating disorders, such as Parkinson's disease, multiple sclerosis, heart disease and spinal cord injuries. However, the breakthrough will also raise serious ethical concerns about the creation of human embryos for medical purposes and the possible use of the same technique to produce IVF embryos for couples wanting their own cloned babies - which is currently illegal in the UK. The scientists who made the advance emphasised that the work is designed to produce replacement tissue for transplant operations from a patient's own skin cells, rather than to improve the chances of so-called reproductive cloning. … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Breakthrough in human cloning raises hopes for treatment of Parkinson's and heart disease

16 Weeks on Testosterone – Video

Posted: Published on May 17th, 2013

16 Weeks on Testosterone Quick update! inkgnosis.tumblr.com. By: gnomadink … Continue reading →

Posted in Testosterone | Comments Off on 16 Weeks on Testosterone – Video

High-testosterone competitors more likely to choose red

Posted: Published on May 17th, 2013

May 16, 2013 Why do so many sports players and athletes choose to wear the color red when they compete? A new study to be published in Psychological Science, a journal of the Association for Psychological Science, suggests that it may have to do with their testosterone levels. The new study, conducted by psychological scientist Daniel Farrelly of the University of Sunderland and colleagues, demonstrated that males who chose red as their color in a competitive task had higher testosterone levels than other males who chose blue. "The research shows that there is something special about the color red in competition, and that it is associated with our underlying biological systems," says Farrelly. The researchers believe that the link may explain why many sports stars wear red clothing -- Tiger Woods, for example, famously chooses to wear a red shirt on the last day of a major competition. Choosing to wear red "may, unconsciously, signal something about their competitive nature, and it may well be something that affects how their opponents respond," Farrelly explains. Farrelly and colleagues recruited 73 men to participate in the study, and they were unaware of the study's aims. The men were told that they would … Continue reading →

Posted in Testosterone | Comments Off on High-testosterone competitors more likely to choose red

Page 5,294«..1020..5,2935,2945,2955,296..5,3005,310..»